Research ArticleOriginal Article
Open Access
Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial
Shuzhen Lai, Peijing Li, Xiaohui Liu, Guihong Liu, Tieming Xie, Xing Zhang, Xiaoxuan Wang, Jing Huang, Yiqiang Tang, Zhigang Liu, Guoping Shen, Chaoming Li, Fangxiao Lu, Lei Wang, Fagui Jiang, Caixing Sun, Yuanyuan Chen and Ming Chen
Cancer Biology & Medicine May 2024, 21 (5) 433-444; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0373
Shuzhen Lai
1Department of Radiation Oncology, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China
2Department of Radiation Oncology, Yuebei People’s Hospital Affiliated to the Medical College of Shantou University, Shaoguan 512026, China
Peijing Li
3Department of Radiation Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences [Zhejiang Cancer Hospital Institute of Basic Medicine and Cancer (IBMC)], Chinese Academy of Sciences, Hangzhou 310022, China
Xiaohui Liu
4Department of Radiation Oncology, The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou 311403, China
Guihong Liu
5Department of Radiation Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221004, China
Tieming Xie
6Department of Radiology, The Cancer Hospital of the University of Chinese Academy of Sciences [Zhejiang Cancer Hospital Institute of Basic Medicine and Cancer (IBMC)], Chinese Academy of Sciences, Hangzhou 310022, China
Xing Zhang
7State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing 210000, China
Xiaoxuan Wang
7State Key Laboratory of Translational Medicine and Innovative Drug Development, Jiangsu Simcere Diagnostics Co., Ltd, Nanjing 210000, China
Jing Huang
8Department of Radiation Oncology, The Affiliated Huai’an First People’s Hospital of Nanjing Medical University, Huai’an 223399, China
Yiqiang Tang
9Department of Radiation Oncology, Jiangxi Cancer Hospital of Nanchang University, Nanchang 330029, China
Zhigang Liu
10Department of Radiotherapy, Dongguan Institute of Clinical Cancer Research, Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, Affiliated Dongguan Hospital, Southern Medical University, Dongguan 523059, China
11The Cancer Center, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai 519000, China
Guoping Shen
12Department of Radiation Oncology, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou 510080, China
Chaoming Li
13Department of Oncology, Maoming People’s Hospital, Maoming 525000, China
Fangxiao Lu
6Department of Radiology, The Cancer Hospital of the University of Chinese Academy of Sciences [Zhejiang Cancer Hospital Institute of Basic Medicine and Cancer (IBMC)], Chinese Academy of Sciences, Hangzhou 310022, China
Lei Wang
3Department of Radiation Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences [Zhejiang Cancer Hospital Institute of Basic Medicine and Cancer (IBMC)], Chinese Academy of Sciences, Hangzhou 310022, China
Fagui Jiang
14Department of Radiation Oncology, Kecheng District People’s Hospital, Quzhou 324003, China
Caixing Sun
15Department of Neurosurgery, The Cancer Hospital of the University of Chinese Academy of Sciences [Zhejiang Cancer Hospital Institute of Basic Medicine and Cancer (IBMC)], Chinese Academy of Sciences, Hangzhou 310022, China
Yuanyuan Chen
16Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
17United Laboratory of Frontier Radiotherapy Technology of Sun Yat-sen University & Chinese Academy of Sciences Ion Medical Technology Co., Ltd, Guangzhou 510060, China
Ming Chen
1Department of Radiation Oncology, The Second Affiliated Hospital of Soochow University, Suzhou 215000, China
16Department of Radiation Oncology, State Key Laboratory of Oncology in South China, Sun Yat-sen University Cancer Center, Guangzhou 510060, China
17United Laboratory of Frontier Radiotherapy Technology of Sun Yat-sen University & Chinese Academy of Sciences Ion Medical Technology Co., Ltd, Guangzhou 510060, China

References
- 1.↵
- 2.↵
- Zhang K,
- Liu X,
- Li G,
- Chang X,
- Li S,
- Chen J, et al.
- 3.↵
- Xu C,
- Yuan X,
- Hou P,
- Li Z,
- Wang C,
- Fang C, et al.
- 4.↵
- Cui X,
- Wang Y,
- Zhou J,
- Wang Q,
- Kang C.
- 5.↵
- Stupp R,
- Mason WP,
- van den Bent MJ,
- Weller M,
- Fisher B,
- Taphoorn MJ, et al.
- 6.↵
- Furnari FB,
- Fenton T,
- Bachoo RM,
- Mukasa A,
- Stommel JM,
- Stegh A, et al.
- 7.↵
- Jain RK,
- di Tomaso E,
- Duda DG,
- Loeffler JS,
- Sorensen AG,
- Batchelor TT.
- 8.↵
- Gilbert MR,
- Dignam JJ,
- Armstrong TS,
- Wefel JS,
- Blumenthal DT,
- Vogelbaum MA, et al.
- 9.↵
- Chinot OL,
- Wick W,
- Mason W,
- Henriksson R,
- Saran F,
- Nishikawa R, et al.
- 10.↵
- 11.↵
- Lee EQ,
- Kaley TJ,
- Duda DG,
- Schiff D,
- Lassman AB,
- Wong ET, et al.
- 12.↵
- Hottinger AF,
- Ben Aissa A,
- Espeli V,
- Squiban D,
- Dunkel N,
- Vargas MI, et al.
- 13.↵
- 14.↵
- Sun X,
- Zhang R,
- Xu J,
- Xie L,
- Guo W.
- 15.↵
- Jiang S,
- Liang H,
- Liu Z,
- Zhao S,
- Liu J,
- Xie Z, et al.
- 16.↵
- Li PJ,
- Lai SZ,
- Jin T,
- Ying HJ,
- Chen YM,
- Zhang P, et al.
- 17.↵
- Garcia J,
- Hurwitz HI,
- Sandler AB,
- Miles D,
- Coleman RL,
- Deurloo R, et al.
- 18.↵
- 19.↵
- Lai Z,
- Markovets A,
- Ahdesmaki M,
- Chapman B,
- Hofmann O,
- McEwen R, et al.
- 20.↵
- 21.↵
- Talevich E,
- Shain AH,
- Botton T,
- Bastian BC.
- 22.↵
- 23.↵
- Curran WJ Jr.,
- Scott CB,
- Horton J,
- Nelson JS,
- Weinstein AS,
- Fischbach AJ, et al.
- 24.↵
- Brandes AA,
- Franceschi E,
- Paccapelo A,
- Tallini G,
- De Biase D,
- Ghimenton C, et al.
- 25.↵
- 26.↵
- Sandmann T,
- Bourgon R,
- Garcia J,
- Li C,
- Cloughesy T,
- Chinot OL, et al.
- 27.↵
- 28.↵
- Álvarez-Satta M,
- Matheu A.
- 29.↵
- Goranci-Buzhala G,
- Mariappan A,
- Ricci-Vitiani L,
- Josipovic N,
- Pacioni S,
- Gottardo M, et al.
- 30.↵
- Li D,
- Chi Y,
- Chen X,
- Ge M,
- Zhang Y,
- Guo Z, et al.
- 31.↵
- Sugita K,
- Kawakami K,
- Yokokawa T,
- Mae Y,
- Toya W,
- Hagino A, et al.
- 32.↵
- Patel S,
- Dushenkov A,
- Jungsuwadee P,
- Krishnaswami A,
- Barac A.
- 33.↵
- Lai A,
- Tran A,
- Nghiemphu PL,
- Pope WB,
- Solis OE,
- Selch M, et al.
In this issue
Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial
Shuzhen Lai, Peijing Li, Xiaohui Liu, Guihong Liu, Tieming Xie, Xing Zhang, Xiaoxuan Wang, Jing Huang, Yiqiang Tang, Zhigang Liu, Guoping Shen, Chaoming Li, Fangxiao Lu, Lei Wang, Fagui Jiang, Caixing Sun, Yuanyuan Chen, Ming Chen
Cancer Biology & Medicine May 2024, 21 (5) 433-444; DOI: 10.20892/j.issn.2095-3941.2023.0373
Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial
Shuzhen Lai, Peijing Li, Xiaohui Liu, Guihong Liu, Tieming Xie, Xing Zhang, Xiaoxuan Wang, Jing Huang, Yiqiang Tang, Zhigang Liu, Guoping Shen, Chaoming Li, Fangxiao Lu, Lei Wang, Fagui Jiang, Caixing Sun, Yuanyuan Chen, Ming Chen
Cancer Biology & Medicine May 2024, 21 (5) 433-444; DOI: 10.20892/j.issn.2095-3941.2023.0373
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.